Mark N. Lampert, 10% Owner at Nivalis Therapeutics, Inc. (NVLS), bought 47,000 shares at $2.25 ($107K) on 2017-05-31, disclosed to the SEC on 2017-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.30 | 1,805 | $4K | 3.9% |
| 2 | $2.30 | 6,903 | $16K | 14.9% |
| 3 | $2.30 | 10,192 | $23K | 22.0% |
| 4 | $2.25 | 2,727 | $6K | 5.8% |
| 5 | $2.25 | 10,023 | $23K | 21.1% |
| 6 | $2.25 | 15,350 |
| $35K |
| 32.4% |
| Total | $2.27 avg | 47,000 | $107K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |